J. Mehilli

J. Mehilli, J. Hausleiter, A. Bauer, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.

J. Mehilli, F. Neumann, R. Tölg, 2014, JAMA.

Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.

R. Lange, A. Pressler, J. Mehilli, 2016, American heart journal.

Restenosis after coronary placement of various stent types.

K Ulm, A. Kastrati, J. Mehilli, 2001, The American journal of cardiology.

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

Jörg Hausleiter, Karl-Ludwig Laugwitz, Ilka Ott, 2011, The New England journal of medicine.

Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss

Jörg Hausleiter, Adnan Kastrati, Albert Schömig, 2006, Circulation.

Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement.

Jörg Hausleiter, Adnan Kastrati, Albert Schömig, 2004, American heart journal.

A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries

J. Hausleiter, A. Kastrati, J. Mehilli, 2004, Journal of internal medicine.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, The New England journal of medicine.

Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry

Samin K. Sharma, J. Mehilli, G. Dangas, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology

K. Kuck, M. Böhm, J. Mehilli, 2015, Clinical Research in Cardiology.

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2003, American heart journal.

Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, Circulation.

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, JAMA.

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization

C. Grines, A. Jacobs, J. Saw, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

[Recanalization of chronic total coronary occlusion: indications and results].

A. Kastrati, J. Mehilli, K. Tiroch, 2010, Deutsche medizinische Wochenschrift.

Clopidogrel therapy in patients undergoing coronary stenting: Value of a high‐loading‐dose regimen

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, JAMA.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003 .

Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.

A. Kastrati, J. Mehilli, A. Schömig, 2000, Circulation.

coronary artery stenting in patients with the DD genotype of the ACE gene Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after

A. Kastrati, J. Mehilli, W. Koch, 2011 .

Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.

A. Kastrati, J. Mehilli, A. Schömig, 2003, Journal of the American College of Cardiology.

Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms.

M. Schwaiger, A. Kastrati, J. Mehilli, 2006, American heart journal.

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Massimo Siviglia, J. Mehilli, G. De Luca, 2021, Atherosclerosis.

Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes.

A. Kastrati, J. Mehilli, A. Schömig, 2008, European heart journal.

HPA-1 and HPA-3 Polymorphisms of the Platelet Fibrinogen Receptor and Coronary Artery Disease and Myocardial Infarction

A. Kastrati, J. Mehilli, A. Schömig, 2000, Thrombosis and Haemostasis.

1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.

K. Kuck, J. Mehilli, F. Neumann, 2015, Journal of the American College of Cardiology.

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting.

A. Kastrati, J. Mehilli, F. Neumann, 2000, Journal of the American College of Cardiology.

Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ

B. Prendergast, A. Baumbach, J. Mehilli, 2017, European heart journal.

Jeroen J. Bax, B. Prendergast, A. Baumbach, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Serum potassium levels on admission and infarct size in patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinica chimica acta; international journal of clinical chemistry.

Analysis of Fibrotic Plaques in Angiographic Manifest Cardiac Allograft Vasculopathy in Long-term Heart Transplanted Patients Using Optical Coherence Tomography

J. Mehilli, J. Hausleiter, C. Hagl, 2021, Transplantation direct.

Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.

J. Mehilli, J. Hausleiter, C. Hagl, 2022, International journal of cardiology.

Platelets contribute to postnatal occlusion of the ductus arteriosus

A. Walch, E. Kremmer, M. Schwaiger, 2010, Nature Medicine.

Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment

A. Kastrati, J. Mehilli, A. Schömig, 2007, Thrombosis and Haemostasis.

1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.

Samin K. Sharma, J. Mehilli, R. Mehran, 2018, JACC. Cardiovascular interventions.

Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF)

J. Mehilli, J. Hausleiter, H. Ince, 2021, International journal of cardiology. Heart & vasculature.

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial.

H. Schunkert, A. Kastrati, J. Mehilli, 2015, Journal of the American College of Cardiology.

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

M. Schwaiger, A. Kastrati, J. Mehilli, 2006, JAMA.

Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis

S. Nekolla, M. Schwaiger, A. Kastrati, 2003, Circulation.

Noninvasive Fractional Flow Reserve and the Heart Team Decision Process: A Shift in Paradigm or Nice to Have?

J. Mehilli, R. Hein, 2019, Circulation. Cardiovascular interventions.

Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

S. Achenbach, A. Schmermund, J. Mehilli, 2019, Clinical Research in Cardiology.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

H. Schunkert, M. Joner, A. Kastrati, 2018, Journal of the American College of Cardiology.

Paclitaxel-Coated Balloon for Recalcitrant In-Drug-Eluting Stent Restenosis.

J. Mehilli, D. Jochheim, 2015, JACC. Cardiovascular interventions.

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.

A. Camm, P. Kirchhof, G. Lip, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction

M. Hadamitzky, J. Hausleiter, H. Schunkert, 2014, Thrombosis and Haemostasis.

Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2013, American heart journal.

The impact of smoking on the antiplatelet action of clopidogrel in non‐ST‐elevation myocardial infarction patients: results from the ISAR‐REACT 4 platelet substudy

A. Kastrati, J. Mehilli, A. Schömig, 2012, Journal of thrombosis and haemostasis : JTH.

Emergency treatment of decompensated aortic stenosis

R. Lange, J. Mehilli, N. Frey, 2017, Heart.

Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2000, Journal of the American College of Cardiology.

Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Circulation. Cardiovascular interventions.

Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry

S. Achenbach, A. Schmermund, J. Mehilli, 2020, Coronary artery disease.

A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI

M. Hadamitzky, J. Mehilli, F. Neumann, 2016, Thrombosis and Haemostasis.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

A. Kastrati, J. Mehilli, H. Schühlen, 2004 .

Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, The New England journal of medicine.

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

A. Kastrati, J. Mehilli, F. Neumann, 2008, Journal of the American College of Cardiology.

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2009, Circulation.

Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.

A. Kastrati, J. Mehilli, F. Neumann, 2010, The American journal of cardiology.

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial

A. Kastrati, J. Mehilli, F. Neumann, 2011, The Lancet.

Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials.

M. Joner, A. Kastrati, J. Mehilli, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

H. Schunkert, A. Kastrati, J. Mehilli, 2014, European heart journal.

Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention

A. Kastrati, J. Mehilli, F. Neumann, 2020, Circulation. Cardiovascular interventions.

Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Clinical cardiology.

Cardiac procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data

A. Jaffe, J. Mehilli, K. Thygesen, 2020, European Heart Journal.

Management of Myocardial Revascularization Failure: An Expert Consensus Document of the EAPCI.

A. Baumbach, J. Mehilli, F. Neumann, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup Analysis

M. Fischer, H. Schunkert, A. Kastrati, 2016, Scientific Reports.

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

J. Mehilli, C. Di Mario, A. Colombo, 2016, JACC. Cardiovascular interventions.

Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry

C. Grines, J. Mehilli, R. Mehran, 2016, Coronary artery disease.

Saphenous Vein Graft Interventions

J. Mehilli, G. Christopoulos, A. Kotsia, 2014, Current Treatment Options in Cardiovascular Medicine.

Degradable polymer drug-eluting stents: a durable benefit?

J. Mehilli, 2013, The Lancet.

Statin treatment following coronary artery stenting and one-year survival.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Journal of the American College of Cardiology.

Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.

Samin K. Sharma, A. Jaffe, S. Ooi, 2020, European heart journal.

Accuracy of N-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease

A. Kastrati, J. Mehilli, A. Schömig, 2007, Cardiology.

Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation.

M. Reiser, J. Mehilli, F. Schwarz, 2014, Clinical radiology.

Bivalirudin vs Heparin in Patients Who Undergo Transcatheter Aortic Valve Implantation.

C. Becker, P. Boekstegers, J. Mehilli, 2015, The Canadian journal of cardiology.

Clinical Research Bivalirudin vs Heparin in Patients Who Undergo Transcatheter Aortic Valve Implantation

C. Becker, P. Boekstegers, J. Mehilli, 2015 .

Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials

G. Stone, A. Kastrati, J. Mehilli, 2012, Circulation. Cardiovascular interventions.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of thrombosis and haemostasis : JTH.

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, Clinical Research in Cardiology.

Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction

M. Schwaiger, A. Kastrati, J. Mehilli, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials

S. Bhattacharya, A. Kastrati, J. Mehilli, 2008, Heart.

Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement

A. Kastrati, J. Mehilli, J. Pache, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2003, Atherosclerosis.

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.

M. Hadamitzky, A. Wieczorek, A. Kastrati, 2011, Journal of the American College of Cardiology.

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

M. Hadamitzky, P. Boekstegers, J. Mehilli, 2017, The Lancet.

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee.

J. Mehilli, M. Morice, V. Kunadian, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sex Differences in Percutaneous Coronary Intervention—Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology

K. Kuck, M. Böhm, J. Mehilli, 2017, Journal of the American Heart Association.

Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.

S. Achenbach, J. Mehilli, C. Di Mario, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.

A. Kastrati, J. Mehilli, A. Schömig, 2010, European heart journal.

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Early Administration of Reteplase Plus Abciximab vs Abciximab Alone in Patients With Acute Myocardial Infarction Referred for Percutaneous Coronary Intervention

Jamie D. Feusner, F. Goodwin, E. O’Brien, 2004 .

Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.

Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care

J. Mehilli, J. Hausleiter, S. Kääb, 2020, Journal of clinical medicine.

Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms.

A. Kastrati, J. Mehilli, A. Schömig, 2009, JAMA.

Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, JAMA.

Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation

A. Kastrati, J. Mehilli, A. Schömig, 2008, Journal of internal medicine.

Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting.

A. Kastrati, J. Mehilli, F. Neumann, 2004, European heart journal.

Glycoprotein IIb/IIIa Receptor Inhibition with Abciximab during Percutaneous Coronary Interventions Increases the Risk of Bleeding in Patients with Impaired Renal Function

A. Kastrati, J. Mehilli, A. Schömig, 2008 .

Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry

Samin K. Sharma, J. Mehilli, G. Dangas, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.

C. Hengstenberg, H. Schunkert, A. Kastrati, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction

Deepak L. Bhatt, F. Rutten, B. Lewis, 2021 .

Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2007, American heart journal.

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2002, Lancet.

N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.

A. Kastrati, J. Mehilli, A. Schömig, 2006, The American journal of medicine.

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.

A. Kastrati, J. Mehilli, A. Schömig, 2005, The American journal of cardiology.

Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy).

A. Kastrati, J. Mehilli, J. Hausleiter, 2016, Thrombosis research.

Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: A randomized double‐blind controlled trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, Journal of the American College of Cardiology.

A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, American heart journal.

PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, Thrombosis and Haemostasis.

Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, Journal of the American College of Cardiology.

Aortic annulus to left coronary distance as a predictor for persistent left bundle branch block after TAVI

J. Mehilli, A. Bauer, S. Massberg, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2010, Clinical Research in Cardiology.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, JACC. Cardiovascular interventions.

Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, M. Seyfarth, 2013, Journal of the American College of Cardiology.

Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, The American journal of cardiology.

Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial

A. Kastrati, J. Mehilli, F. Dotzer, 2011, Clinical Research in Cardiology.

No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

A. Kastrati, J. Mehilli, A. Schömig, 2012, Circulation. Cardiovascular interventions.

SUPPLEMENTAL MATERIAL No Association of ABCB 1 C 3435 T Genotype with Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

A. Kastrati, J. Mehilli, A. Schömig, 2012 .

Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2011, Clinical Research in Cardiology.

Global and regional functional measurements with gated FDG PET in comparison with left ventriculography

K. Ishii, S. Nekolla, M. Schwaiger, 2001, European Journal of Nuclear Medicine.

Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2011, American heart journal.

N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.

S. Nekolla, M. Schwaiger, A. Kastrati, 2006, The American journal of cardiology.

Myocardial Salvage after Reduced-Dose Thrombolysis Combined with Glycoprotein IIb/IIIa Blockade Versus Thrombolysis Alone in Patients with Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of Thrombosis and Thrombolysis.

Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, European heart journal.

ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2012, Cardiology journal.

High-sensitivity troponin T level and angiographic severity of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2011, The American journal of cardiology.

Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Clinical Research in Cardiology.

Saphenous vein graft intervention.

G. Stone, Seung‐Jung Park, A. Kirtane, 2011, JACC: Cardiovascular Interventions.

Drug-eluting Stents in Diabetic Patients

J. Mehilli, G. Ndrepepa, 2006 .

Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.

J. Mehilli, J. Hausleiter, S. Massberg, 2016, JACC. Cardiovascular interventions.

Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2005, Clinica chimica acta; international journal of clinical chemistry.

Circulating homocysteine levels in patients with type 2 diabetes mellitus.

A. Kastrati, J. Mehilli, A. Schömig, 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Revista espanola de cardiologia.

Impact of prosthesis‐iteration evolution and sizing practice on the incidence of prosthesis–patient mismatch after transcatheter aortic valve replacement

J. Mehilli, F. Neumann, G. Richardt, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Local Anesthesia for Surgical Repair of TF - TAVI Access - Site Lesions

J. Mehilli, J. Werner, G. Gäbel, 2018 .

One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.

J. Mehilli, J. Hausleiter, F. Schwarz, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Platelet Reactivity and Early Outcomes after Transfemoral Aortic Valve Implantation

J. Mehilli, L. Holdt, D. Teupser, 2018, Thrombosis and Haemostasis.

Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.

A. Kastrati, J. Mehilli, A. Schömig, 2010, American heart journal.

Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

E. D. Lorenzo, A. Kastrati, J. Mehilli, 2010, Clinical Research in Cardiology.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST‐EU Registry

J. Mehilli, C. Di Mario, A. Colombo, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents

A. Kastrati, J. Mehilli, A. Schömig, 2008, Cardiology.

Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)

C. Hengstenberg, M. Fischer, H. Schunkert, 2014 .

COMPARISON OF TWO SUTURE MEDIATED CLOSURE DEVICES FOR ACCESS SITE CLOSURE AFTER TRANSFEMORAL AORTIC VALVE IMPLANTATION

J. Hausleiter, J. Mehilli, G. Richardt, 2015 .

Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors

A. Kastrati, J. Mehilli, A. Schömig, 2010, Thrombosis and Haemostasis.

Lessons Learned From In Vitro Durability Testing of Transcatheter Heart Valves.

J. Mehilli, 2020, JACC. Cardiovascular interventions.

Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis

A. Kastrati, J. Mehilli, A. Schömig, 2012, Thrombosis and Haemostasis.

Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI)

C. Hengstenberg, J. Mehilli, T. Walther, 2018, European heart journal.

Extracorporal life support (ECLS) in acute ischaemic cardiogenic shock

J. Mehilli, J. Hausleiter, S. Sattler, 2014, International journal of clinical practice.

Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction

J. Mehilli, Stefanie Schüpke, 2017, European heart journal.

Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The American journal of cardiology.

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

A. Kastrati, J. Mehilli, A. Schömig, 2018 .

G protein beta3 subunit polymorphism and risk of thrombosis and restenosis following coronary stent placement.

A. Kastrati, J. Mehilli, M. Seyfarth, 2000, Atherosclerosis.

The year in cardiovascular medicine 2021: interventional cardiology

F. Jaffer, J. Mehilli, R. Mehran, 2022, Cardiologia Croatica.

Impact of severe left ventricular outflow tract calcification on device failure and short-term mortality in patients undergoing TAVI.

J. Mehilli, J. Hausleiter, B. Bischoff, 2019, Journal of cardiovascular computed tomography.

The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry

J. Mehilli, R. Mehran, A. Kini, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

J. Mehilli, C. Di Mario, A. Colombo, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high load

A. Kastrati, J. Mehilli, J. Dirschinger, 1997, American heart journal.

Systolic or diastolic CT image acquisition for transcatheter aortic valve replacement - An outcome analysis.

J. Mehilli, J. Hausleiter, C. Hagl, 2022, Journal of cardiovascular computed tomography.

Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomized, Double-Blind Trial

M. Hadamitzky, M. Schwaiger, A. Kastrati, 2010, Circulation. Cardiovascular interventions.

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.

C. Hengstenberg, H. Schunkert, M. Joner, 2014, JAMA.

Corrigendum to: Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.

Samin K. Sharma, A. Jaffe, S. Ooi, 2021, European heart journal.

Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.

Adnan Kastrati, Albert Schömig, A. Kastrati, 2010, American heart journal.

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

Adnan Kastrati, Albert Schömig, A. Kastrati, 2009, Journal of the American College of Cardiology.

Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

Munich, A. Kastrati, J. Mehilli, 2012, Journal of the American College of Cardiology.

Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivity

Stefan Brunner, J. Mehilli, L. Holdt, 2016, Platelets.

Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.

A. Kastrati, J. Mehilli, J. Hausleiter, 2009, JACC. Cardiovascular interventions.

A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.

S. Steinhubl, A. Kastrati, J. Mehilli, 2004, Journal of the American College of Cardiology.

Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Clinical science.

No difference in 30-day outcome and quality of life in transradial versus transfemoral access - Results from the German Austrian ABSORB registry (GABI-R).

S. Achenbach, J. Mehilli, T. Riemer, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.

Samin K. Sharma, J. Mehilli, R. Mehran, 2016, JACC. Cardiovascular interventions.

Acute and 30-day Outcomes in Women After TAVR : Results From the First Women in Transcatheter Aortic Valve Implantation ( WIN-TAVI ) Real World Registry

J. Mehilli, R. Mehran, M. Morice, 2016 .

Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice.

A. Kastrati, J. Mehilli, C. Hamm, 2020, International Journal of Cardiology.

Predictors of early scaffold thrombosis: results from the multicenter prospective German–Austrian ABSORB RegIstRy

W. Rottbauer, S. Achenbach, A. Schmermund, 2018, Coronary artery disease.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

S. Achenbach, A. Schmermund, J. Mehilli, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R.

S. Achenbach, A. Schmermund, J. Mehilli, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry.

Samin K. Sharma, J. Mehilli, G. Dangas, 2020, International journal of cardiology.

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

D. Atar, C. Held, B. Lewis, 2022, European heart journal.

Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry

Samin K. Sharma, P. Nihoyannopoulos, J. Mehilli, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Obesity Paradox in the Clinical Significance of Effective Prosthetic Orifice Area After Aortic Valve Replacement

J. Mehilli, J. Hausleiter, B. Bischoff, 2022 .

Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, American heart journal.

Long-Term Prognostic Impact of Restenosis of the Unprotected Left Main Coronary Artery Requiring Repeat Revascularization.

H. Schunkert, A. Kastrati, J. Mehilli, 2020, JACC. Cardiovascular interventions.

Left main coronary artery disease: when and how to perform PCI?

J. Mehilli, M. Chiarito, 2020, Minerva cardioangiologica.

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.

A. Kastrati, J. Mehilli, F. Neumann, 2001, Lancet.

Distribution of angiographic measures of restenosis after drug-eluting stent implantation

A. Kastrati, J. Mehilli, A. Schömig, 2009, Heart.

Coronary artery disease and acute coronary syndrome in women

J. Mehilli, P. Presbitero, 2020, Heart.

Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2005, American heart journal.

Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, Circulation.

A. Kastrati, J. Mehilli, F. Neumann, 2013, American heart journal.

Response to Letter Regarding Article, “Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention”

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012 .

Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

H. Schunkert, A. Kastrati, J. Mehilli, 2022 .

Percutaneous edge‐to‐edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation

A. Kastrati, J. Mehilli, J. Pache, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Left main coronary artery compression in a young woman with Eisenmenger syndrome

J. Mehilli, A. Hager, H. Kaemmerer, 2011, Heart Asia.

A. Kastrati, J. Mehilli, A. Schömig, 2012, Journal of the American College of Cardiology.

Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?

F. Jaffer, J. Mehilli, J. Escaned, 2021, European heart journal.

Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

H. Thiele, A. Kastrati, J. Mehilli, 2020, European heart journal.

Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart

J. Grapsa, J. Mehilli, E. Grove, 2021, European heart journal.

The year in cardiovascular medicine 2021: interventional cardiology

F. Jaffer, J. Mehilli, R. Mehran, 2022, European heart journal.

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry

S. Achenbach, A. Schmermund, J. Mehilli, 2019, Journal of clinical medicine.

Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German‐Austrian ABSORB RegIstRy

S. Achenbach, A. Schmermund, J. Mehilli, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry

Samin K. Sharma, J. Mehilli, R. Mehran, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry).

Samin K. Sharma, J. Mehilli, G. Dangas, 2022, The American journal of cardiology.

Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

J. Mehilli, R. Mehran, M. Morice, 2019, The American journal of cardiology.

Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry.

J. Mehilli, R. Mehran, M. Morice, 2018, Journal of cardiovascular computed tomography.

Acute and 30-Day Outcomes in WomenAfter TAVR

Samin K. Sharma, J. Mehilli, R. Mehran, 2022 .

Severe Left Ventricular Outflow Tract Calcification Is Associated With Poor Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.

J. Mehilli, J. Hausleiter, B. Bischoff, 2019, JACC. Cardiovascular imaging.

Permanent pacemaker dependency in patients with new left bundle branch block and new first degree atrioventricular block after transcatheter aortic valve implantation

J. Mehilli, S. Fichtner, S. Massberg, 2021, Scientific Reports.

ISAR-LEFT MAIN 2 Trial: Zotarolimus- versus Everolimus- Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions

J. Mehilli, T. Rizzo, 2012 .

Percutaneous revascularisation of chronic occluded coronaries - availability of the retrograde approach increases technical success and the quality of life despite more frequent complications.

J. Mehilli, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.

A. Kastrati, J. Mehilli, F. Neumann, 2001, The American journal of cardiology.

Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.

A. Kastrati, J. Mehilli, F. Neumann, 2013, Journal of interventional cardiology.

Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction

J. Mehilli, N. Haas, A. Lehner, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The VELETI II Trial (Sealing Moderate Coronary Saphenous Vein Graft Lesions With Paclitaxel-Eluting Stents): Local Mechanical Intervention Fails to Stop Atheroprogression in Saphenous Vein Grafts.

J. Mehilli, 2016, Circulation. Cardiovascular interventions.

Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement

A. Kastrati, J. Mehilli, F. Neumann, 2001, Circulation.

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Deepak L. Bhatt, F. Rutten, B. Lewis, 2020, European heart journal.

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.

A. Kastrati, J. Mehilli, A. Schömig, 2008, European heart journal.

ABO locus O1 allele and risk of myocardial infarction

A. Kastrati, J. Mehilli, A. Schömig, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes

A. Kastrati, J. Mehilli, A. Schömig, 2008, European journal of clinical investigation.

CLINICAL RESEARCH Interventional Cardiology Influence of Treatment Duration With a 600-mg Dose of Clopidogrel Before Percutaneous Coronary Revascularization

S. Steinhubl, A. Kastrati, J. Mehilli, 2004 .

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

M. Pfisterer, Seung‐Jung Park, P. Jüni, 2007, Journal of the American College of Cardiology.

Hybrid Surgery for Severe Mitral Valve Calcification: Limitations and Caveats for an Open Transcatheter Approach

J. Mehilli, A. Oberbach, C. Hagl, 2022, Medicina.

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Deepak L. Bhatt, F. Rutten, B. Lewis, 2021, Revista espanola de cardiologia.

2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015, Revista espanola de cardiologia.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.

Adnan Kastrati, Albert Schömig, Melchior Seyfarth, 2008, Journal of the American College of Cardiology.

Everolimus-Eluting Versus Sirolimus-Eluting Stents: A Meta-Analysis of Randomized Trials

A. Kastrati, J. Mehilli, A. Schömig, 2011, Circulation. Cardiovascular interventions.

Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantation - Results from EVERY-TAVI registry.

J. Hausleiter, J. Mehilli, F. Schwarz, 2017, International journal of cardiology.

Transcatheter Aortic Valve Replacement in Extremely Large Annuli: (Over)expanding Bioprosthetic Technology to the Limits?

J. Mehilli, D. Jochheim, 2018, JACC. Cardiovascular interventions.

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, JAMA.

Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial

A. Kastrati, J. Mehilli, J. Pache, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic value of uric acid in patients with acute coronary syndromes.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2012, The American journal of cardiology.

2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation.

Baris Gencer, Marco Valgimigli, Marco Roffi, 2015, Revista espanola de cardiologia.

Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

M. Schwaiger, A. Kastrati, J. Mehilli, 2000, The New England journal of medicine.

Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2001, Atherosclerosis.

Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.

Adnan Kastrati, Markus Schwaiger, Albert Schömig, 2007, Journal of the American College of Cardiology.

Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2000, Blood.

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.

A. Kastrati, J. Mehilli, D. Sibbing, 2013, Journal of the American College of Cardiology.

ACS and STEMI treatment: gender-related issues.

J. Mehilli, R. Mehran, M. Morice, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Journal of the American College of Cardiology.

Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials)

A. Kastrati, J. Mehilli, D. Sibbing, 2015, BioMed research international.

Gender Differences in Cardiovascular Therapy: Focus on Antithrombotic Therapy and Percutaneous Coronary Intervention

J. Mehilli, J. Gutiérrez-Chico, 2013, Drugs.

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, JAMA.

Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer population

J. Mehilli, J. Hausleiter, Stefanie Schüpke, 2018, Journal of geriatric cardiology : JGC.

One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, European heart journal.

Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.

J. Mehilli, A. Hapfelmeier, A. Colombo, 2019, JACC. Cardiovascular interventions.

Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of thrombosis and haemostasis : JTH.

No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.

A. Kastrati, J. Mehilli, A. Schömig, 2009, JACC. Cardiovascular interventions.

Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: Rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R).

S. Achenbach, A. Schmermund, J. Mehilli, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

Antonio Colombo, Tommaso Gori, Salvatore Geraci, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2004, The American journal of cardiology.

Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2009, Journal of the American College of Cardiology.

Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of the American College of Cardiology.

Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.

J. Mehilli, J. Hausleiter, C. Hagl, 2020, International journal of cardiology.

Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2001, Atherosclerosis.

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.

A. Wieczorek, A. Kastrati, J. Mehilli, 2008, European heart journal.

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.

Kurt Ulm, Adnan Kastrati, Albert Schömig, 2005, JAMA.

CLINICAL RESEARCH Interventional Cardiology A Randomized Trial Comparing Myocardial Salvage Achieved by Coronary Stenting Versus Balloon Angioplasty in Patients With Acute Myocardial Infarction Considered Ineligible for Reperfusion Therapy

Adnan Kastrati, Markus Schwaiger, Albert Schömig, 2004 .

Gender and restenosis after coronary artery stenting.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, European heart journal.

PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.

A. Kastrati, J. Mehilli, A. Schömig, 2000, Journal of the American College of Cardiology.

ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

ISAR-REACT 3 A : a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2022 .

CLINICAL RESEARCH Acute Coronary Syndromes Gender and Myocardial Salvage After Reperfusion Treatment in Acute Myocardial Infarction

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, JAMA.

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.

A. Kastrati, J. Mehilli, M. Seyfarth, 1999, Circulation.

Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.

A. Kastrati, J. Mehilli, A. Schömig, 2009, European heart journal.

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

Walter Desmet, Karl-Ludwig Laugwitz, Yi Li, 2015, European heart journal.

Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation.

P. Boekstegers, G. Steinbeck, A. Kastrati, 1999, Circulation.

Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.

A. Kastrati, J. Mehilli, F. Neumann, 2008, European heart journal.

Have Women with Coronary Artery Disease a Higher Risk than Men after Coronary Stenting

J. Mehilli, 2002 .

Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2010, European heart journal.

A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery Disease

A. Kastrati, J. Mehilli, J. Dirschinger, 2000 .

Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial

M. Hadamitzky, J. Mehilli, F. Neumann, 2018, European heart journal.

Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, The American journal of medicine.

Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.

A. Kastrati, J. Mehilli, J. Dirschinger, 2008, American Journal of Cardiology.

Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2002, The Lancet.

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Thrombosis and Haemostasis.

A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention

A. Kastrati, J. Mehilli, F. Neumann, 2010, Heart and Vessels.

Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, European heart journal.

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The New England journal of medicine.

Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR‐DIRECT trial)

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.

A. Kastrati, J. Mehilli, A. Schömig, 2003, European heart journal.

A randomized trial comparing the hand‐mounted JoStent with the premounted Multi‐Link Duet stent in patients with coronary artery disease

A. Kastrati, J. Mehilli, J. Dirschinger, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, Circulation.

Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, The American journal of cardiology.

Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.

A. Kastrati, J. Mehilli, A. Schömig, 2009, JACC. Cardiovascular interventions.

urability of Antirestenotic Efficacy n Drug-Eluting Stents With and ithout Permanent Polymer

A. Kastrati, J. Mehilli, A. Schömig, 2022 .

Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2014, European heart journal cardiovascular Imaging.

Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, American heart journal.

ISAR--a story of trials with impact on practice.

A. Kastrati, J. Mehilli, A. Schömig, 2010, Circulation journal : official journal of the Japanese Circulation Society.

A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes

A. Kastrati, J. Mehilli, A. Schömig, 2006, Clinical Research in Cardiology.

Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2006, Journal of the American College of Cardiology.

P ost Analysis From Two Randomized Trials of irolimus-Eluting Stents Versus Paclitaxel-Eluting tents in High-Risk Patients With Coronary Artery Disease

A. Kastrati, J. Mehilli, A. Dibra, 2006 .

Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.

A. Kastrati, J. Mehilli, J. Pache, 2007, American heart journal.

Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus.

A. Kastrati, J. Mehilli, J. Pache, 2004, The American journal of medicine.

Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of medicine.

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial

A. Kastrati, J. Mehilli, F. Neumann, 2001, The Lancet.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Marco Valgimigli, Manel Sabaté, Adnan Kastrati, 2007, The New England journal of medicine.

Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, Circulation.

Reply: Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation.

A. Kastrati, J. Mehilli, D. Sibbing, 2015, Journal of the American College of Cardiology.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stent

A. Kastrati, J. Mehilli, F. Neumann, 2009, American heart journal.

Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions

A. Kastrati, J. Mehilli, A. Schömig, 2007, Thrombosis and Haemostasis.

Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting Published, JLR Papers in Press, October 1, 2004. DOI 10.1194/jlr.M400148-JLR200

A. Pfeufer, A. Kastrati, J. Mehilli, 2004, Journal of Lipid Research.

Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries

A. Kastrati, J. Mehilli, A. Schömig, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, Cardiology.

Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.

A. Kastrati, J. Mehilli, D. Sibbing, 2014, American heart journal.

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

Massimo Siviglia, J. Mehilli, D. Dudek, 2020, Journal of the American College of Cardiology.

Long-Term Outcomes After MitraClip Implantation According to the Presence or Absence of EVEREST Inclusion Criteria.

M. Hadamitzky, H. Schunkert, A. Kastrati, 2017, The American journal of cardiology.

Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge Repair Technique in the Presence and Absence of Pacemaker Leads.

J. Mehilli, J. Hausleiter, A. Bauer, 2017, JACC. Cardiovascular interventions.

Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique.

J. Mehilli, J. Hausleiter, A. Bauer, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2006, Clinica chimica acta; international journal of clinical chemistry.

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis

A. Kastrati, J. Mehilli, J. Dirschinger, 2005 .

Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2010, The American journal of cardiology.

Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients.

E. Hannan, P. Nihoyannopoulos, J. Mehilli, 2018, International journal of cardiology.

The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.

M. Hadamitzky, H. Schunkert, A. Kastrati, 2015, Thrombosis research.

Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).

Samin K. Sharma, J. Mehilli, R. Mehran, 2018, The American journal of cardiology.

Glycoprotein IIIa PIA polymorphism and early outcome after coronary stenting in patients with adjunctive abciximab therapy

A. Kastrati, J. Mehilli, A. Schömig, 2003 .

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Journal of the American College of Cardiology.

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, European heart journal.

Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention

A. Kastrati, J. Mehilli, M. Seyfarth, 2010, Heart and Vessels.

Polymer-free drug-eluting stents for coronary artery disease.

J. Mehilli, D. Jochheim, M. Baquet, 2018, Journal of interventional cardiology.

Stent Polymers: Do They Make a Difference?

J. Mehilli, K. Rizas, Julinda Mehilli, 2016, Circulation. Cardiovascular interventions.

Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography

M. Joner, A. Kastrati, J. Mehilli, 2014, The International Journal of Cardiovascular Imaging.

Everolimus-Eluting Versus Sirolimus-Eluting StentsClinical Perspective

A. Kastrati, J. Mehilli, A. Schömig, 2011 .

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.

A. Kastrati, J. Mehilli, M. Seyfarth, 2009, European heart journal.

Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Clinical Research in Cardiology.

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey.

J. Mehilli, M. Morice, V. Kunadian, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Overcoming professional barriers encountered by women in interventional cardiology: an EAPCI statement.

J. Mehilli, M. Morice, V. Kunadian, 2023, European heart journal.

Effects of verbal suggestion on coronary arteries: results of a randomized controlled experimental investigation during coronary angiography.

P. Henningsen, J. Mehilli, J. Ronel, 2011, American heart journal.

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

A. Kastrati, J. Mehilli, F. Neumann, 2013, The Lancet.

Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention

A. Kastrati, J. Mehilli, A. Schömig, 2009, Circulation. Cardiovascular interventions.

Six‐month outcome after transcatheter edge‐to‐edge repair of severe tricuspid regurgitation in patients with heart failure

J. Mehilli, J. Hausleiter, C. Besler, 2018, European journal of heart failure.

Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction.

A. Kastrati, J. Mehilli, J. Pache, 2015, The American journal of cardiology.

Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Journal of the American College of Cardiology.

A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, Circulation.

Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography.

Stephan G Nekolla, Markus Schwaiger, S. Nekolla, 2002, Journal of the American College of Cardiology.

Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort.

Samin K. Sharma, J. Wykrzykowska, J. Mehilli, 2022, International journal of cardiology.

Intervention-Based Strategy in Patients With Stable Coronary Artery Disease A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary

Adnan Kastrati, Albert Schömig, Melchior Seyfarth, 2011 .

Bioprosthetic valves for transcatheter aortic valve replacement--reply.

J. Mehilli, G. Richardt, M. Abdel-Wahab, 2014, JAMA.

Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.

A. Kastrati, J. Mehilli, A. Schömig, 2008, American heart journal.

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.

Marco Valgimigli, Adnan Kastrati, Christoph Kaiser, 2007, European heart journal.

Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment

S. Steinhubl, A. Kastrati, J. Mehilli, 2010, Thrombosis and Haemostasis.

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

A. Kastrati, J. Mehilli, M. Seyfarth, 2014, JACC. Cardiovascular interventions.

Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial.

J. Brachmann, K. Stangl, J. Mehilli, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair.

P. Boekstegers, J. Mehilli, J. Hausleiter, 2015, Journal of interventional cardiology.

Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials

H. Schunkert, A. Kastrati, J. Mehilli, 2015, Clinical Research in Cardiology.

CORONARY ARTERY DISEASE Original Studies Angiographic Outcomes With Biodegradable Polymer and Permanent Polymer Drug-Eluting Stents

A. Kastrati, J. Mehilli, A. Schömig, 2011 .

Intracoronary Stenting and Angiographic Results : Test Efficacy of 3 Limus-Eluting Stents ( ISAR-TEST-4 ) Trial Investigators

A. Kastrati, J. Mehilli, A. Schömig, 2011 .

Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.

A. Kastrati, J. Mehilli, J. Pache, 2006, Journal of the American College of Cardiology.

The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.

J. Mehilli, S. Halvorsen, 2022, European Heart Journal.

The occupational effects of interventional cardiology: results from the WIN for Safety survey.

J. Mehilli, R. Mehran, M. Morice, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

CT-Determined Tricuspid Annular Dilatation Is Associated With Increased 2-Year Mortality in TAVR Patients.

J. Mehilli, J. Hausleiter, C. Hagl, 2020, JACC. Cardiovascular interventions.

Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus

H. Schunkert, M. Joner, A. Kastrati, 2021, Journal of the American Heart Association.

Five‐year clinical outcomes of a polymer‐free sirolimus‐eluting stent versus a permanent polymer paclitaxel‐eluting stent: Final results of the intracoronary stenting and angiographic restenosis – test equivalence between two drug‐eluting stents (ISAR‐TEST) trial

Adnan Kastrati, Albert Schömig, A. Kastrati, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.

A. Kastrati, J. Mehilli, J. Pache, 2011, Circulation.

Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results

J. Mehilli, S. Kufner, K. Laugwitz, 2009, Heart.

Long‐term prognostic value of risk scores after drug‐eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR‐LEFT‐MAIN and ISAR‐LEFT‐MAIN 2 randomized clinical trials

H. Schunkert, A. Kastrati, J. Mehilli, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation.

J. Mehilli, J. Hausleiter, A. Schömig, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

TAVR in nonagenarians: An analysis investigating safety, efficacy, symptomatic improvement, and long-term survival.

J. Hausleiter, J. Mehilli, C. Hagl, 2021, Journal of cardiology.

Predictors for long‐term survival after transcatheter edge‐to‐edge mitral valve repair

H. Schunkert, P. Boekstegers, A. Kastrati, 2017, Journal of interventional cardiology.

Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.

A. Kastrati, J. Mehilli, J. Pache, 2007, European heart journal.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

J. Mehilli, C. Di Mario, A. Colombo, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation.

Samin K. Sharma, J. Mehilli, G. Dangas, 2023, The American journal of cardiology.

Randomized Comparison of a Titanium-Nitride-Oxide–Coated Stent With a Stainless Steel Stent for Coronary Revascularization: The TiNOX Trial

F. Eberli, O. Hess, A. Kastrati, 2005, Circulation.

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina

A. Kastrati, J. Mehilli, A. Schömig, 2005, Circulation.

Revisiting the BIOSCIENCE of drug-eluting stent technology

J. Mehilli, S. Massberg, 2014, The Lancet.

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.

A. Kastrati, J. Mehilli, Raphaela Lohaus, 2016, JACC. Cardiovascular interventions.

Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial.

A. Wieczorek, A. Kastrati, J. Mehilli, 2007, Journal of the American College of Cardiology.

Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.

A. Kastrati, J. Mehilli, M. Seyfarth, 2007, Journal of the American College of Cardiology.

Efficacy of Tricuspid Valve Direct Annuloplasty and Valve Anatomical Configuration.

J. Mehilli, F. Zauner, 2023, JACC: Cardiovascular Interventions.

Three-dimensional transoesophageal echocardiography for the assessment of clip attachment to the leaflets in percutaneous edge-to-edge repair of the mitral valve.

A. Kastrati, J. Mehilli, J. Pache, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.

Samin K. Sharma, J. Mehilli, R. Mehran, 2019, The Canadian journal of cardiology.

Risk-treatment paradox in women with symptomatic coronary artery disease

J. Mehilli, L. King, Lamin A. King, 2013, Clinical Research in Cardiology Supplements.

Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry

J. Mehilli, C. Di Mario, A. Colombo, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting☆

J. Mehilli, S. Braun, A. Dibra, 2003 .

Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of cardiology.

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

Jörg Hausleiter, Karl-Ludwig Laugwitz, Ilka Ott, 2011, American heart journal.

Cytochrome P 450 2 C 19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

A. Kastrati, J. Mehilli, A. Schömig, 2009 .

ComparisonofBalloon-ExpandablevsSelf-expandableValves inPatientsUndergoingTranscatheterAorticValveReplacement The CHOICE Randomized Clinical Trial

J. Mehilli, F. Neumann, R. Tölg, 2014 .

A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease)

F. Eberli, A. Wieczorek, A. Kastrati, 2012 .

Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients

Karl-Ludwig Laugwitz, Adnan Kastrati, Albert Schömig, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].

A. Kastrati, J. Mehilli, J. Pache, 2008, Revista espanola de cardiologia.

CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2002, American heart journal.

Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST‐EU registry

J. Mehilli, C. Di Mario, A. Colombo, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation

J. Mehilli, G. Guagliumi, S. Massberg, 2017, Journal of interventional cardiology.

Gender Differences in Surgical Patients Suffering from Active Infective Endocarditis (AIE)

J. Mehilli, J. Garbade, A. Oberbach, 2018, The Thoracic and Cardiovascular Surgeon.

Retrospective analysis of circulatory support with the Impella CP® device in patients with therapy refractory cardiogenic shock.

J. Mehilli, J. Hausleiter, S. Sattler, 2016, International journal of cardiology.

Hybrid‐stenting with metallic and bioresorbable drug‐eluting stents 2‐year clinical outcomes in KUM ABSORB registry

J. Mehilli, C. Tesche, S. Massberg, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Jeroen J. Bax, J. Mehilli, S. Windecker, 2011, European heart journal.

[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

J. Mehilli, S. Windecker, C. Patrono, 2016, Giornale italiano di cardiologia.

2023 ESC Guidelines for the management of acute coronary syndromes.

B. Lewis, S. Antoniou, L. Fauchier, 2023, European heart journal.

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

C. Terkelsen, J. Mehilli, B. Iung, 2022, European heart journal. Quality of care & clinical outcomes.

[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015, Kardiologia polska.

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) - Nice, France, 20-21 June 2018.

P. Vardas, A. Baumbach, J. Mehilli, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sex Differences in Percutaneous Coronary Intervention—Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology

K. Kuck, J. Mehilli, M. Hochadel, 2017, Journal of the American Heart Association.

European Society of Cardiology Quality Indicators for the Cardiovascular Preoperative Assessment and Management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology & Intensive Care.

T. Potpara, J. Mehilli, O. Tutarel, 2022, European heart journal. Quality of care & clinical outcomes.

H. Schunkert, A. Kastrati, J. Mehilli, 2017 .

CORONARY ARTERY DISEASE Original Studies Second-Versus First-Generation ‘‘Limus’’-Eluting Stents in Diabetic Patients with Coronary Artery Disease: A Randomized Comparison in Setting of ISAR-TEST-4 Trial

A. Kastrati, J. Mehilli, J. Pache, 2013 .

Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.

A. Kastrati, J. Mehilli, A. Schömig, 2004, Atherosclerosis.

Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation.

J. Mehilli, J. Hausleiter, S. Peterss, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

B. Lewis, J. Mehilli, S. Windecker, 2016 .

Abstract 2147: Drug-Eluting Stents Versus Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: A Pooled Patient-Level Analysis of 7 Randomized Trials.

A. Kastrati, J. Mehilli, A. Schömig, 2007 .

Jeroen J. Bax, J. Mehilli, S. Windecker, 2016, Giornale italiano di cardiologia.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015 .

Stent?: Results of the ISAR-PEACE Randomized Trial Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting

A. Wieczorek, J. Mehilli, A. Schömig, 2007 .

2023 ESC Guidelines for the management of acute coronary syndromes.

L. Fauchier, L. Neubeck, L. Räber, 2023, European heart journal. Acute cardiovascular care.

A. Kastrati, J. Mehilli, A. Schömig, 2012, Journal of the American College of Cardiology.

No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.

A. Kastrati, J. Mehilli, A. Schömig, 2011, European heart journal.

Prognostic Value of a High On-clopidogrel Treatment Platelet Reactivity in Bivalirudin versus Abciximab Treated Non–st-segment Elevation Myocardial Infarction Patients Isar-react 4 (intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) Platelet Substudy

Munich, A. Kastrati, J. Mehilli, 2022 .

A. Kastrati, J. Mehilli, A. Schömig, 2010, Journal of the American College of Cardiology.

M. Schwaiger, A. Kastrati, J. Mehilli, 2002, Circulation.

Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis

A. Kastrati, J. Mehilli, A. Schömig, 2012, Thrombosis and Haemostasis.

H. Schunkert, A. Kastrati, J. Mehilli, 2014, Clinical cardiology.

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

A. Kastrati, J. Mehilli, A. Schömig, 2009, Journal of the American College of Cardiology.

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.

C. Hengstenberg, H. Schunkert, M. Joner, 2014, JAMA.

Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2009, Circulation.

Efficacy Over Time With Drug-Eluting Stents in Saphenous Vein Graft Lesions.

H. Schunkert, M. Joner, A. Kastrati, 2018, Journal of the American College of Cardiology.

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

A. Kastrati, J. Mehilli, F. Neumann, 2011, The New England journal of medicine.

Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation.

J. Mehilli, J. Hausleiter, A. Bauer, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Stent Polymers: Do They Make a Difference?

J. Mehilli, K. Rizas, 2016, Circulation. Cardiovascular interventions.

Retrospective analysis of circulatory support with the Impella CP® device in patients with therapy refractory cardiogenic shock.

J. Mehilli, H. Theiss, U. Grabmaier, 2016, International journal of cardiology.

[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

Jeroen J. Bax, J. Mehilli, S. Windecker, 2015, Kardiologia polska.

Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

S. Achenbach, A. Schmermund, J. Mehilli, 2019, Clinical Research in Cardiology.

A. Kastrati, J. Mehilli, F. Neumann, 2013, Journal of interventional cardiology.

Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.

A. Kastrati, J. Mehilli, W. Koch, 2000, Blood.

TCT-12 Impact of overlap on long-term clinical outcomes in patients undergoing everolimus-eluting bioresorbable vascular scaffolds implantation in routine clinical practice: insights from the European multicenter GHOST-EU registry

J. Mehilli, A. Colombo, S. Brugaletta, 2015 .

Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the Association for Acute Cardiovascular (ACVC) and the ESC Working Group

J. Mehilli, D. Dudek, M. Czerny, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, Journal of the American College of Cardiology.

Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection

J. Mehilli, Benito Baldauf, Stefan Borov, 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, JAMA.

Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, American heart journal.

[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].

A. Kastrati, J. Mehilli, J. Dirschinger, 2012, Vestnik rentgenologii i radiologii.

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

M. Fischer, H. Schunkert, A. Kastrati, 2017, Thrombosis and Haemostasis.

Sensitive troponin and N‐terminal probrain natriuretic peptide in stable angina

A. Kastrati, J. Mehilli, M. Seyfarth, 2011, European journal of clinical investigation.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004 .

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry

A. Schmermund, J. Mehilli, T. Riemer, 2022, BMC Cardiovascular Disorders.

Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.

A. Kastrati, J. Mehilli, M. Seyfarth, 2008, Journal of the American College of Cardiology.

’ s response to reviews Title : Prognostic value of frailty in elderly patients with acute coronary syndrome : A systematic review and meta-analysis

Jeroen J. Bax, Y. Liu, J. Mehilli, 2019 .

1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves Results From the CHOICE Randomized Clinical Trial

J. Mehilli, D. Richardt, M. Abdel-Wahab, 2017 .

Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials

A. Kastrati, J. Mehilli, M. Schalij, 2010, Clinical Research in Cardiology.

Treatment of acute cardiac tamponade: A retrospective analysis of classical intermittent versus continuous pericardial drainage

J. Mehilli, J. Hausleiter, Moritz F. Sinner, 2021, International journal of cardiology. Heart & vasculature.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.

Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.

Samin K. Sharma, J. Mehilli, G. Dangas, 2023, The Canadian journal of cardiology.

No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting

A. Kastrati, J. Mehilli, A. Schömig, 2012, Circulation. Cardiovascular interventions.